Infant Bacterial Therapeutics AB (IBT-B.ST) Q1 2026 Earnings

6FebConfirmed
Q4 2024
Q1 2025
Q4 2025
Q1 2026
-1.4
-1.18
-0.96
-0.75

Details

Expected EPS
N/A
Actual EPS
-1.3953035954
Surprise EPS
-1.4
Surprise Percent
+∞%

Description

Infant Bacterial Therapeutics AB (IBT-B.ST) has reported earnings of -1.3953035954 per share for Q1 2026.

0 Comments

Share your thoughts